Laird Norton Trust Company, LLC Inmune Bio, Inc. Call Options Transaction History
Laird Norton Trust Company, LLC
- $621 Million
- Q1 2025
Call Options
1 transactions
Others Institutions Holding INMB
# of Institutions
93Shares Held
6.77MCall Options Held
317KPut Options Held
104K-
Praetorian Pr LLC Rincon, PR865KShares$2.27 Million2.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA827KShares$2.17 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$2.13 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.56 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL382KShares$1 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $47M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...